Global Telmisartan Market Insights and Forecast to 2028

Report ID: 1127067 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
1 Study Coverage
    1.1 Telmisartan Product Introduction
    1.2 Market by Type
        1.2.1 Global Telmisartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Injection
        1.2.3 Freeze-Dried Powder
    1.3 Market by Application
        1.3.1 Global Telmisartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Telmisartan Sales Estimates and Forecasts 2017-2028
    2.2 Global Telmisartan Revenue Estimates and Forecasts 2017-2028
    2.3 Global Telmisartan Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Telmisartan Sales by Region
        2.4.1 Global Telmisartan Sales by Region (2017-2022)
        2.4.2 Global Sales Telmisartan by Region (2023-2028)
    2.5 Global Telmisartan Revenue by Region
        2.5.1 Global Telmisartan Revenue by Region (2017-2022)
        2.5.2 Global Telmisartan Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Telmisartan Sales by Manufacturers
        3.1.1 Global Top Telmisartan Manufacturers by Sales (2017-2022)
        3.1.2 Global Telmisartan Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Telmisartan in 2021
    3.2 Global Telmisartan Revenue by Manufacturers
        3.2.1 Global Telmisartan Revenue by Manufacturers (2017-2022)
        3.2.2 Global Telmisartan Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Telmisartan Revenue in 2021
    3.3 Global Telmisartan Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Telmisartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Telmisartan Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Telmisartan Sales by Type
        4.1.1 Global Telmisartan Historical Sales by Type (2017-2022)
        4.1.2 Global Telmisartan Forecasted Sales by Type (2023-2028)
        4.1.3 Global Telmisartan Sales Market Share by Type (2017-2028)
    4.2 Global Telmisartan Revenue by Type
        4.2.1 Global Telmisartan Historical Revenue by Type (2017-2022)
        4.2.2 Global Telmisartan Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Telmisartan Revenue Market Share by Type (2017-2028)
    4.3 Global Telmisartan Price by Type
        4.3.1 Global Telmisartan Price by Type (2017-2022)
        4.3.2 Global Telmisartan Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Telmisartan Sales by Application
        5.1.1 Global Telmisartan Historical Sales by Application (2017-2022)
        5.1.2 Global Telmisartan Forecasted Sales by Application (2023-2028)
        5.1.3 Global Telmisartan Sales Market Share by Application (2017-2028)
    5.2 Global Telmisartan Revenue by Application
        5.2.1 Global Telmisartan Historical Revenue by Application (2017-2022)
        5.2.2 Global Telmisartan Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Telmisartan Revenue Market Share by Application (2017-2028)
    5.3 Global Telmisartan Price by Application
        5.3.1 Global Telmisartan Price by Application (2017-2022)
        5.3.2 Global Telmisartan Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Telmisartan Market Size by Type
        6.1.1 North America Telmisartan Sales by Type (2017-2028)
        6.1.2 North America Telmisartan Revenue by Type (2017-2028)
    6.2 North America Telmisartan Market Size by Application
        6.2.1 North America Telmisartan Sales by Application (2017-2028)
        6.2.2 North America Telmisartan Revenue by Application (2017-2028)
    6.3 North America Telmisartan Market Size by Country
        6.3.1 North America Telmisartan Sales by Country (2017-2028)
        6.3.2 North America Telmisartan Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Telmisartan Market Size by Type
        7.1.1 Europe Telmisartan Sales by Type (2017-2028)
        7.1.2 Europe Telmisartan Revenue by Type (2017-2028)
    7.2 Europe Telmisartan Market Size by Application
        7.2.1 Europe Telmisartan Sales by Application (2017-2028)
        7.2.2 Europe Telmisartan Revenue by Application (2017-2028)
    7.3 Europe Telmisartan Market Size by Country
        7.3.1 Europe Telmisartan Sales by Country (2017-2028)
        7.3.2 Europe Telmisartan Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Telmisartan Market Size by Type
        8.1.1 Asia Pacific Telmisartan Sales by Type (2017-2028)
        8.1.2 Asia Pacific Telmisartan Revenue by Type (2017-2028)
    8.2 Asia Pacific Telmisartan Market Size by Application
        8.2.1 Asia Pacific Telmisartan Sales by Application (2017-2028)
        8.2.2 Asia Pacific Telmisartan Revenue by Application (2017-2028)
    8.3 Asia Pacific Telmisartan Market Size by Region
        8.3.1 Asia Pacific Telmisartan Sales by Region (2017-2028)
        8.3.2 Asia Pacific Telmisartan Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Telmisartan Market Size by Type
        9.1.1 Latin America Telmisartan Sales by Type (2017-2028)
        9.1.2 Latin America Telmisartan Revenue by Type (2017-2028)
    9.2 Latin America Telmisartan Market Size by Application
        9.2.1 Latin America Telmisartan Sales by Application (2017-2028)
        9.2.2 Latin America Telmisartan Revenue by Application (2017-2028)
    9.3 Latin America Telmisartan Market Size by Country
        9.3.1 Latin America Telmisartan Sales by Country (2017-2028)
        9.3.2 Latin America Telmisartan Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Telmisartan Market Size by Type
        10.1.1 Middle East and Africa Telmisartan Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Telmisartan Revenue by Type (2017-2028)
    10.2 Middle East and Africa Telmisartan Market Size by Application
        10.2.1 Middle East and Africa Telmisartan Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Telmisartan Revenue by Application (2017-2028)
    10.3 Middle East and Africa Telmisartan Market Size by Country
        10.3.1 Middle East and Africa Telmisartan Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Telmisartan Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Corporation Information
        11.1.2 Pfizer Overview
        11.1.3 Pfizer Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Pfizer Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Pfizer Recent Developments
    11.2 Teva
        11.2.1 Teva Corporation Information
        11.2.2 Teva Overview
        11.2.3 Teva Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Teva Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Teva Recent Developments
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Corporation Information
        11.3.2 Boehringer Ingelheim Overview
        11.3.3 Boehringer Ingelheim Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Boehringer Ingelheim Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Boehringer Ingelheim Recent Developments
    11.4 Novartis
        11.4.1 Novartis Corporation Information
        11.4.2 Novartis Overview
        11.4.3 Novartis Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Novartis Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Novartis Recent Developments
    11.5 Mylan
        11.5.1 Mylan Corporation Information
        11.5.2 Mylan Overview
        11.5.3 Mylan Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Mylan Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Mylan Recent Developments
    11.6 Reddy's Laboratories (UK)
        11.6.1 Reddy's Laboratories (UK) Corporation Information
        11.6.2 Reddy's Laboratories (UK) Overview
        11.6.3 Reddy's Laboratories (UK) Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Reddy's Laboratories (UK) Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Reddy's Laboratories (UK) Recent Developments
    11.7 Hema Pharmaceuticals Pvt
        11.7.1 Hema Pharmaceuticals Pvt Corporation Information
        11.7.2 Hema Pharmaceuticals Pvt Overview
        11.7.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Hema Pharmaceuticals Pvt Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Hema Pharmaceuticals Pvt Recent Developments
    11.8 Bayer
        11.8.1 Bayer Corporation Information
        11.8.2 Bayer Overview
        11.8.3 Bayer Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Bayer Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Bayer Recent Developments
    11.9 GSK
        11.9.1 GSK Corporation Information
        11.9.2 GSK Overview
        11.9.3 GSK Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 GSK Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 GSK Recent Developments
    11.10 Astellas Pharma Inc
        11.10.1 Astellas Pharma Inc Corporation Information
        11.10.2 Astellas Pharma Inc Overview
        11.10.3 Astellas Pharma Inc Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Astellas Pharma Inc Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Astellas Pharma Inc Recent Developments
    11.11 Nippon Boehringer Ingelheim
        11.11.1 Nippon Boehringer Ingelheim Corporation Information
        11.11.2 Nippon Boehringer Ingelheim Overview
        11.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Nippon Boehringer Ingelheim Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Nippon Boehringer Ingelheim Recent Developments
    11.12 Abbott
        11.12.1 Abbott Corporation Information
        11.12.2 Abbott Overview
        11.12.3 Abbott Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Abbott Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Abbott Recent Developments
    11.13 Takeda
        11.13.1 Takeda Corporation Information
        11.13.2 Takeda Overview
        11.13.3 Takeda Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Takeda Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Takeda Recent Developments
    11.14 Beijing Wansheng Pharmaceutical
        11.14.1 Beijing Wansheng Pharmaceutical Corporation Information
        11.14.2 Beijing Wansheng Pharmaceutical Overview
        11.14.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Beijing Wansheng Pharmaceutical Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Beijing Wansheng Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Telmisartan Industry Chain Analysis
    12.2 Telmisartan Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Telmisartan Production Mode & Process
    12.4 Telmisartan Sales and Marketing
        12.4.1 Telmisartan Sales Channels
        12.4.2 Telmisartan Distributors
    12.5 Telmisartan Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Telmisartan Industry Trends
    13.2 Telmisartan Market Drivers
    13.3 Telmisartan Market Challenges
    13.4 Telmisartan Market Restraints
14 Key Findings in The Global Telmisartan Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Telmisartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Injection
    Table 3. Major Manufacturers of Freeze-Dried Powder
    Table 4. Global Telmisartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Telmisartan Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Telmisartan Sales by Region (2017-2022) & (MT)
    Table 7. Global Telmisartan Sales Market Share by Region (2017-2022)
    Table 8. Global Telmisartan Sales by Region (2023-2028) & (MT)
    Table 9. Global Telmisartan Sales Market Share by Region (2023-2028)
    Table 10. Global Telmisartan Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Telmisartan Revenue Market Share by Region (2017-2022)
    Table 12. Global Telmisartan Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Telmisartan Revenue Market Share by Region (2023-2028)
    Table 14. Global Telmisartan Sales by Manufacturers (2017-2022) & (MT)
    Table 15. Global Telmisartan Sales Share by Manufacturers (2017-2022)
    Table 16. Global Telmisartan Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Telmisartan Revenue Share by Manufacturers (2017-2022)
    Table 18. Telmisartan Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 19. Global Telmisartan Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Telmisartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Telmisartan as of 2021)
    Table 21. Telmisartan Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Telmisartan Product Offered
    Table 23. Date of Manufacturers Enter into Telmisartan Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Telmisartan Sales by Type (2017-2022) & (MT)
    Table 26. Global Telmisartan Sales by Type (2023-2028) & (MT)
    Table 27. Global Telmisartan Sales Share by Type (2017-2022)
    Table 28. Global Telmisartan Sales Share by Type (2023-2028)
    Table 29. Global Telmisartan Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Telmisartan Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Telmisartan Revenue Share by Type (2017-2022)
    Table 32. Global Telmisartan Revenue Share by Type (2023-2028)
    Table 33. Telmisartan Price by Type (2017-2022) & (USD/Kg)
    Table 34. Global Telmisartan Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 35. Global Telmisartan Sales by Application (2017-2022) & (MT)
    Table 36. Global Telmisartan Sales by Application (2023-2028) & (MT)
    Table 37. Global Telmisartan Sales Share by Application (2017-2022)
    Table 38. Global Telmisartan Sales Share by Application (2023-2028)
    Table 39. Global Telmisartan Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Telmisartan Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Telmisartan Revenue Share by Application (2017-2022)
    Table 42. Global Telmisartan Revenue Share by Application (2023-2028)
    Table 43. Telmisartan Price by Application (2017-2022) & (USD/Kg)
    Table 44. Global Telmisartan Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 45. North America Telmisartan Sales by Type (2017-2022) & (MT)
    Table 46. North America Telmisartan Sales by Type (2023-2028) & (MT)
    Table 47. North America Telmisartan Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Telmisartan Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Telmisartan Sales by Application (2017-2022) & (MT)
    Table 50. North America Telmisartan Sales by Application (2023-2028) & (MT)
    Table 51. North America Telmisartan Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Telmisartan Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Telmisartan Sales by Country (2017-2022) & (MT)
    Table 54. North America Telmisartan Sales by Country (2023-2028) & (MT)
    Table 55. North America Telmisartan Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Telmisartan Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Telmisartan Sales by Type (2017-2022) & (MT)
    Table 58. Europe Telmisartan Sales by Type (2023-2028) & (MT)
    Table 59. Europe Telmisartan Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Telmisartan Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Telmisartan Sales by Application (2017-2022) & (MT)
    Table 62. Europe Telmisartan Sales by Application (2023-2028) & (MT)
    Table 63. Europe Telmisartan Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Telmisartan Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Telmisartan Sales by Country (2017-2022) & (MT)
    Table 66. Europe Telmisartan Sales by Country (2023-2028) & (MT)
    Table 67. Europe Telmisartan Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Telmisartan Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Telmisartan Sales by Type (2017-2022) & (MT)
    Table 70. Asia Pacific Telmisartan Sales by Type (2023-2028) & (MT)
    Table 71. Asia Pacific Telmisartan Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Telmisartan Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Telmisartan Sales by Application (2017-2022) & (MT)
    Table 74. Asia Pacific Telmisartan Sales by Application (2023-2028) & (MT)
    Table 75. Asia Pacific Telmisartan Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Telmisartan Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Telmisartan Sales by Region (2017-2022) & (MT)
    Table 78. Asia Pacific Telmisartan Sales by Region (2023-2028) & (MT)
    Table 79. Asia Pacific Telmisartan Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Telmisartan Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Telmisartan Sales by Type (2017-2022) & (MT)
    Table 82. Latin America Telmisartan Sales by Type (2023-2028) & (MT)
    Table 83. Latin America Telmisartan Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Telmisartan Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Telmisartan Sales by Application (2017-2022) & (MT)
    Table 86. Latin America Telmisartan Sales by Application (2023-2028) & (MT)
    Table 87. Latin America Telmisartan Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Telmisartan Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Telmisartan Sales by Country (2017-2022) & (MT)
    Table 90. Latin America Telmisartan Sales by Country (2023-2028) & (MT)
    Table 91. Latin America Telmisartan Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Telmisartan Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Telmisartan Sales by Type (2017-2022) & (MT)
    Table 94. Middle East and Africa Telmisartan Sales by Type (2023-2028) & (MT)
    Table 95. Middle East and Africa Telmisartan Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Telmisartan Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Telmisartan Sales by Application (2017-2022) & (MT)
    Table 98. Middle East and Africa Telmisartan Sales by Application (2023-2028) & (MT)
    Table 99. Middle East and Africa Telmisartan Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Telmisartan Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Telmisartan Sales by Country (2017-2022) & (MT)
    Table 102. Middle East and Africa Telmisartan Sales by Country (2023-2028) & (MT)
    Table 103. Middle East and Africa Telmisartan Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Telmisartan Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Pfizer Corporation Information
    Table 106. Pfizer Description and Major Businesses
    Table 107. Pfizer Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 108. Pfizer Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Pfizer Recent Developments
    Table 110. Teva Corporation Information
    Table 111. Teva Description and Major Businesses
    Table 112. Teva Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 113. Teva Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Teva Recent Developments
    Table 115. Boehringer Ingelheim Corporation Information
    Table 116. Boehringer Ingelheim Description and Major Businesses
    Table 117. Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 118. Boehringer Ingelheim Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Boehringer Ingelheim Recent Developments
    Table 120. Novartis Corporation Information
    Table 121. Novartis Description and Major Businesses
    Table 122. Novartis Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 123. Novartis Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Novartis Recent Developments
    Table 125. Mylan Corporation Information
    Table 126. Mylan Description and Major Businesses
    Table 127. Mylan Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 128. Mylan Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Mylan Recent Developments
    Table 130. Reddy's Laboratories (UK) Corporation Information
    Table 131. Reddy's Laboratories (UK) Description and Major Businesses
    Table 132. Reddy's Laboratories (UK) Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 133. Reddy's Laboratories (UK) Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Reddy's Laboratories (UK) Recent Developments
    Table 135. Hema Pharmaceuticals Pvt Corporation Information
    Table 136. Hema Pharmaceuticals Pvt Description and Major Businesses
    Table 137. Hema Pharmaceuticals Pvt Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 138. Hema Pharmaceuticals Pvt Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Hema Pharmaceuticals Pvt Recent Developments
    Table 140. Bayer Corporation Information
    Table 141. Bayer Description and Major Businesses
    Table 142. Bayer Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 143. Bayer Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Bayer Recent Developments
    Table 145. GSK Corporation Information
    Table 146. GSK Description and Major Businesses
    Table 147. GSK Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 148. GSK Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. GSK Recent Developments
    Table 150. Astellas Pharma Inc Corporation Information
    Table 151. Astellas Pharma Inc Description and Major Businesses
    Table 152. Astellas Pharma Inc Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 153. Astellas Pharma Inc Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Astellas Pharma Inc Recent Developments
    Table 155. Nippon Boehringer Ingelheim Corporation Information
    Table 156. Nippon Boehringer Ingelheim Description and Major Businesses
    Table 157. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 158. Nippon Boehringer Ingelheim Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Nippon Boehringer Ingelheim Recent Developments
    Table 160. Abbott Corporation Information
    Table 161. Abbott Description and Major Businesses
    Table 162. Abbott Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 163. Abbott Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Abbott Recent Developments
    Table 165. Takeda Corporation Information
    Table 166. Takeda Description and Major Businesses
    Table 167. Takeda Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 168. Takeda Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Takeda Recent Developments
    Table 170. Beijing Wansheng Pharmaceutical Corporation Information
    Table 171. Beijing Wansheng Pharmaceutical Description and Major Businesses
    Table 172. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 173. Beijing Wansheng Pharmaceutical Telmisartan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Beijing Wansheng Pharmaceutical Recent Developments
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Telmisartan Distributors List
    Table 178. Telmisartan Customers List
    Table 179. Telmisartan Market Trends
    Table 180. Telmisartan Market Drivers
    Table 181. Telmisartan Market Challenges
    Table 182. Telmisartan Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Telmisartan Product Picture
    Figure 3. Global Telmisartan Market Share by Type in 2021 & 2028
    Figure 3. Injection Product Picture
    Figure 4. Freeze-Dried Powder Product Picture
    Figure 5. Global Telmisartan Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Clinic
    Figure 8. Others
    Figure 9. Telmisartan Report Years Considered
    Figure 10. Global Telmisartan Sales 2017-2028 (MT)
    Figure 11. Global Telmisartan Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Telmisartan Revenue 2017-2028 (US$ Million)
    Figure 13. Global Telmisartan Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Telmisartan Sales Market Share by Region (2017-2022)
    Figure 15. Global Telmisartan Sales Market Share by Region (2023-2028)
    Figure 16. North America Telmisartan Sales YoY (2017-2028) & (MT)
    Figure 17. North America Telmisartan Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Telmisartan Sales YoY (2017-2028) & (MT)
    Figure 19. Europe Telmisartan Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Telmisartan Sales YoY (2017-2028) & (MT)
    Figure 21. Asia-Pacific Telmisartan Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Telmisartan Sales YoY (2017-2028) & (MT)
    Figure 23. Latin America Telmisartan Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Telmisartan Sales YoY (2017-2028) & (MT)
    Figure 25. Middle East & Africa Telmisartan Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Telmisartan Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Telmisartan in the World: Market Share by Telmisartan Revenue in 2021
    Figure 28. Global Telmisartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Telmisartan Sales Market Share by Type (2017-2028)
    Figure 30. Global Telmisartan Revenue Market Share by Type (2017-2028)
    Figure 31. Global Telmisartan Sales Market Share by Application (2017-2028)
    Figure 32. Global Telmisartan Revenue Market Share by Application (2017-2028)
    Figure 33. North America Telmisartan Sales Market Share by Type (2017-2028)
    Figure 34. North America Telmisartan Revenue Market Share by Type (2017-2028)
    Figure 35. North America Telmisartan Sales Market Share by Application (2017-2028)
    Figure 36. North America Telmisartan Revenue Market Share by Application (2017-2028)
    Figure 37. North America Telmisartan Sales Share by Country (2017-2028)
    Figure 38. North America Telmisartan Revenue Share by Country (2017-2028)
    Figure 39. U.S. Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Telmisartan Sales Market Share by Type (2017-2028)
    Figure 42. Europe Telmisartan Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Telmisartan Sales Market Share by Application (2017-2028)
    Figure 44. Europe Telmisartan Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Telmisartan Sales Share by Country (2017-2028)
    Figure 46. Europe Telmisartan Revenue Share by Country (2017-2028)
    Figure 47. Germany Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 48. France Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Telmisartan Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Telmisartan Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Telmisartan Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Telmisartan Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Telmisartan Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Telmisartan Revenue Share by Region (2017-2028)
    Figure 58. China Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 61. India Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Telmisartan Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Telmisartan Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Telmisartan Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Telmisartan Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Telmisartan Sales Share by Country (2017-2028)
    Figure 73. Latin America Telmisartan Revenue Share by Country (2017-2028)
    Figure 74. Mexico Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Telmisartan Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Telmisartan Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Telmisartan Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Telmisartan Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Telmisartan Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Telmisartan Revenue Share by Country (2017-2028)
    Figure 83. Turkey Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Telmisartan Revenue (2017-2028) & (US$ Million)
    Figure 86. Telmisartan Value Chain
    Figure 87. Telmisartan Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy's Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
Frequently Asked Questions
Telmisartan report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Telmisartan report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Telmisartan report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Children's Beds

Children's Beds market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Salon Furniture

Salon Furniture market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Toilet Assembly

Toilet Assembly market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More